XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
Derivatives
12 Months Ended
Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives

5. Derivatives

Interest Rate Swaps

The Company enters into interest rate swap transactions from time to time to hedge fixed rate debt obligations and certain fixed rate debt investments. The Company’s interest rate swaps are all with one counterparty and are centrally cleared through a registered commodities exchange. Refer to the Consolidated Schedule of Investments for additional disclosure regarding these interest rate swaps.

Cash flows related to the Company's derivatives are included within operating activities on the Consolidated Statements of Cash Flows. The following tables present the amounts paid and received on the Company’s interest rate swap transactions for the year ended December 31, 2023 and 2022:

 

 

 

 

 

 

 

 

For the Year Ended December 31, 2023

 

 

 

Maturity Date

 

Notional Amount

 

 

Paid

 

 

Received

 

 

Net

 

Interest rate swap (1)

 

1/22/2023

 

$

 

 

$

(663

)

 

$

431

 

 

$

(232

)

Interest rate swap

 

11/1/2024

 

 

300,000

 

 

 

(22,776

)

 

 

11,625

 

 

 

(11,151

)

Interest rate swap

 

11/1/2024

 

 

50,000

 

 

 

(3,903

)

 

 

1,938

 

 

 

(1,965

)

Interest rate swap

 

11/1/2024

 

 

2,500

 

 

 

(97

)

 

 

191

 

 

 

94

 

Interest rate swap

 

8/1/2026

 

 

300,000

 

 

 

(21,745

)

 

 

7,479

 

 

 

(14,266

)

Interest rate swap

 

8/14/2028

 

 

300,000

 

 

 

(9,306

)

 

 

7,587

 

 

 

(1,719

)

Total

 

 

 

$

952,500

 

 

$

(58,490

)

 

$

29,251

 

 

$

(29,239

)

 

(1)
As of December 31, 2023, these interest rate swaps had either matured or been terminated due to repayment of the underlying
investment or security.

 

 

 

 

 

 

 

 

For the Year Ended December 31, 2022

 

 

 

Maturity Date

 

Notional Amount

 

 

Paid

 

 

Received

 

 

Net

 

Interest rate swap (1)

 

8/1/2022

 

$

115,000

 

 

$

(2,158

)

 

$

3,048

 

 

$

890

 

Interest rate swap (1)

 

8/1/2022

 

 

50,000

 

 

 

(706

)

 

 

1,325

 

 

 

619

 

Interest rate swap (1)

 

8/1/2022

 

 

7,500

 

 

 

(106

)

 

 

198

 

 

 

92

 

Interest rate swap (1)

 

8/1/2022

 

 

27,531

 

 

 

(730

)

 

 

474

 

 

 

(256

)

Interest rate swap (1)

 

8/1/2022

 

 

2,160

 

 

 

(57

)

 

 

37

 

 

 

(20

)

Interest rate swap (1)

 

8/1/2022

 

 

42,819

 

 

 

(1,135

)

 

 

737

 

 

 

(398

)

Interest rate swap

 

1/22/2023

 

 

150,000

 

 

 

(5,728

)

 

 

6,750

 

 

 

1,022

 

Interest rate swap

 

11/1/2024

 

 

300,000

 

 

 

(12,227

)

 

 

11,625

 

 

 

(602

)

Interest rate swap

 

11/1/2024

 

 

50,000

 

 

 

(2,144

)

 

 

1,938

 

 

 

(206

)

Interest rate swap

 

11/1/2024

 

 

2,500

 

 

 

(97

)

 

 

103

 

 

 

6

 

Interest rate swap

 

8/1/2026

 

 

300,000

 

 

 

(11,196

)

 

 

7,479

 

 

 

(3,717

)

Total

 

 

 

$

1,047,510

 

 

$

(36,284

)

 

$

33,714

 

 

$

(2,570

)

 

(1)
As of December 31, 2022, these interest rate swaps had either matured or been terminated due to repayment of the underlying investment or security.

For the years ended December 31, 2023 and 2022, the Company recognized a $0.1 million net change in unrealized gains and a $6.7 million net change in unrealized losses, respectively, on interest rate swaps not designated as hedging instruments in the Consolidated Statement of Operations related to the swap transactions. For the year ended December 31, 2022, the Company recognized $2.3 million in realized gains on interest rate swaps not designated as hedging instruments in the Consolidated Statement of Operations related to. For the year ended December 31, 2023 the company recognized a $23.2 million net change in gains on interest rate swaps designated as hedging instruments as a component of interest expense in the Consolidated Statement of Operation. For the year ended December 31, 2023 the company recognized no net realized gain or loss on interest rate swaps. For the year ended December 31, 2022 the Company recognized a $49.2 million net change in losses on interest rate swaps designated as hedging instruments as a component of interest expense in the Consolidated Statement of Operations. For the years ended December 31, 2023 and 2022, this amount is offset by an increase of $9.0 million and a decrease of $23.8 million, respectively, for a change in the carrying value of the 2024 Notes and for the years ended December 31, 2023 and 2022, an increase of $9.6 million and $25.4 million, respectively, for a change in carrying value of the 2026 Notes. For the year ended December 31, 2023 this amount is additionally offset by an increase of $4.7 million for a change in carrying value of the 2028 Notes.

As of December 31, 2023, the swap transactions had a fair value of $(31.8) million which is netted against cash collateral on the Company’s Consolidated Balance Sheet. As of December 31, 2022, the swap transactions had a fair value of $(55.3) million which is netted against cash collateral on the Company’s Consolidated Balance Sheet.

The Company is required under the terms of its derivatives agreements to pledge assets as collateral to secure its obligations underlying the derivatives. The amount of collateral required varies over time based on the mark-to-market value, notional amount and remaining term of the derivatives, and may exceed the amount owed by the Company on a mark-to-market basis. Any failure by the Company to fulfill any collateral requirement (e.g., a so-called “margin call”) may result in a default. In the event of a default by a counterparty, the Company would be an unsecured creditor to the extent of any such overcollateralization.

As of December 31, 2023 and 2022, $24.0 million and $15.4 million, respectively, of cash is pledged as collateral under the Company’s derivative agreements and is included in restricted cash as a component of cash and cash equivalents on the Company’s Consolidated Balance Sheet.

The Company may enter into other derivative instruments and incur other exposures with the same or other counterparties in the future.